RecruitingNot ApplicableNCT07300904

Tensi+ for Treating Overactive Bladder

A Randomized, Controlled, Blinded, Prospective, Multi-center Study Evaluating Tensi+ With Transcutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder Syndrome

Sponsor

Stimuli Technology

Enrollment

60 participants

Start Date

May 26, 2026

Study Type

INTERVENTIONAL

Conditions

Overactive Bladder (OAB)

Summary

The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Tensi+ for people with overactive bladder (oab). The study is currently recruiting participants at 3 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETensi+

Transcutaneous Tibial Nerve Stimulation

Locations(3)

Cedars-Sinai

Beverly Hills, California, United States

NYU Langone Health

New York, New York, United States

Toronto Western Hospital

Toronto, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07300904

Related Trials

Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive Bladder

NCT07540273

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

NCT07553065